DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study

Martin Bjerregård Pedersen, Stephen Jacques Hamilton-Dutoit, Knud Bendix, Rhett P. Ketterling, Patrick P. Bedroske, Ivy M. Luoma, Christopher A. Sattler, Rebecca L. Boddicker, N. Nora Bennani, Peter Nørgaard, Michael Boe Møller, Torben Steiniche, Francesco D’Amore*, Andrew L. Feldman

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

117 Scopus citations
Original languageEnglish (US)
Pages (from-to)554-557
Number of pages4
JournalBlood
Volume130
Issue number4
DOIs
StatePublished - Jul 27 2017

Funding

The authors thank Kristina Lauridsen (Laboratory of Molecular Pathology, Aarhus University Hospital), Lindsay B. Emanuel (Department of Health Sciences Research, Mayo Clinic), and Kathryn E. Pearce (Department of Laboratory Medicine and Pathology, Mayo Clinic) for excellent technical and logistic assistance. This work was supported by grants from the Institute of Clinical Medicine, Aarhus University/Aarhus University Hospital, The Karen Elise Jensen Foundation, The A. P. Møller and Chastine Mc-Kinney Møller Foundation for General Purposes, The Eva and Henry Frænkel Foundation, The Mimi & Victor Larsens Fund, the National Institutes of Health, National Cancer Institute (R01 CA177734 and P50 CA97274), and the Department of Laboratory Medicine and Pathology, Mayo Clinic.

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this